492 related articles for article (PubMed ID: 19031640)
1. Mirtazapine-induced manic switch in adolescent unipolar depression.
Goyal N; Sinha VK
Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
[No Abstract] [Full Text] [Related]
2. Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
Moustgaard G
J Clin Psychopharmacol; 2000 Apr; 20(2):268. PubMed ID: 10770470
[No Abstract] [Full Text] [Related]
3. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine induced mania in a woman with major depression in the absence of features of bipolarity.
Basavraj V; Nanjundappa GB; Chandra PS
Aust N Z J Psychiatry; 2011 Oct; 45(10):901. PubMed ID: 21692606
[No Abstract] [Full Text] [Related]
5. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
Adetunji B; Basil B; Mathews M; Osinowo T
Ann Pharmacother; 2007 Feb; 41(2):359. PubMed ID: 17244643
[No Abstract] [Full Text] [Related]
6. [Switch to mania].
Ohgake S; Iyo M
Ryoikibetsu Shokogun Shirizu; 2003; (38):379-80. PubMed ID: 12877007
[No Abstract] [Full Text] [Related]
7. Mirtazapine and hyperpigmentation.
Mendhekar D; Inamdar A
World J Biol Psychiatry; 2009; 10(4 Pt 2):688-9. PubMed ID: 19404867
[No Abstract] [Full Text] [Related]
8. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
[No Abstract] [Full Text] [Related]
9. Acute reversible dyskinesia induced by mirtazapine.
Konitsiotis S; Pappa S; Mantas C; Mavreas V
Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
[No Abstract] [Full Text] [Related]
10. Predictors of efficacy in lithium augmentation for treatment-resistant depression.
Sugawara H; Sakamoto K; Harada T; Ishigooka J
J Affect Disord; 2010 Sep; 125(1-3):165-8. PubMed ID: 20089312
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
12. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
Varia I; Venkataraman S; Hellegers C; Gersing K; Doraiswamy PM
Psychopharmacol Bull; 2007; 40(1):47-56. PubMed ID: 17285095
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycaemia secondary to mirtazapine therapy in a 37-year-old man.
Chen R; Lopes J
Aust N Z J Psychiatry; 2008 Nov; 42(11):990-1. PubMed ID: 18946939
[No Abstract] [Full Text] [Related]
14. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
[TBL] [Abstract][Full Text] [Related]
15. Mania associated with mirtazepine treatment and mixed depression.
Habermeyer B; Bayer U; Müller-Spahn F
Pharmacopsychiatry; 2010 Jan; 43(1):37-8. PubMed ID: 20178094
[No Abstract] [Full Text] [Related]
16. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
Wålinder J; Prochazka J; Odén A; Sjödin I; Dahl ML; Ahlner J; Bengtsson F
Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
[TBL] [Abstract][Full Text] [Related]
19. [Mirtazapine in inpatient treatment of depressed patients].
Bailer U; Praschak-Rieder N; Pezawas L; Kasper S
Wien Klin Wochenschr; 1998 Oct; 110(18):646-50. PubMed ID: 9816638
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
Haapasalo-Pesu KM; Vuola T; Lahelma L; Marttunen M
J Child Adolesc Psychopharmacol; 2004; 14(2):175-84. PubMed ID: 15319015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
